BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A, Efrati C, Franceschilli M, Guida AM, Ingallinella S, Montagnese F, Sensi B, Siragusa L, Sica GS. Pathophysiology of Crohn's disease inflammation and recurrence. Biol Direct 2020;15:23. [PMID: 33160400 DOI: 10.1186/s13062-020-00280-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nazari H, Naei VY, Tabasi AH, Badripour A, Akbari Asbagh R, Keramati MR, Sharifi A, Behboudi B, Kazemeini A, Abbasi M, Keshvari A, Ahmadi Tafti SM. Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease. Inflamm Bowel Dis 2021:izab151. [PMID: 34291798 DOI: 10.1093/ibd/izab151] [Reference Citation Analysis]
2 Hadji H, Bouchemal K. Advances in the Treatment of Inflammatory Bowel Disease: Focus on Polysaccharide Nanoparticulate Drug Delivery Systems. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114101] [Reference Citation Analysis]
3 Djelouah M, Marical V, Kanagaratnam L, Kianmanesh R, Biron A, Cadiot G, Hoeffel C. Diagnosis of postoperative recurrence of Crohn disease with MR-enterography: Value of diffusion-weighted imaging. Diagn Interv Imaging 2021:S2211-5684(21)00145-5. [PMID: 34154981 DOI: 10.1016/j.diii.2021.06.002] [Reference Citation Analysis]
4 Yao L, Zhu X, Shao B, Liu R, Li Z, Wu L, Chen J, Cao Q. Reasons and Factors Contributing to Chinese Patients' Preference for Ustekinumab in Crohn's Disease: A Multicenter Cross-Sectional Study. Front Pharmacol 2021;12:736149. [PMID: 34887751 DOI: 10.3389/fphar.2021.736149] [Reference Citation Analysis]
5 Ingallinella S, Campanelli M, Antonelli A, Arcudi C, Bellato V, Divizia A, Franceschilli M, Petagna L, Sensi B, Sibio S, Siragusa L, Sica GS. The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence. Gastroenterol Res Pract 2020;2020:2845407. [PMID: 33456458 DOI: 10.1155/2020/2845407] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yu B, Yin YX, Tang YP, Wei KL, Pan ZG, Li KZ, Guo XW, Hu BL. Diagnostic and Predictive Value of Immune-Related Genes in Crohn's Disease. Front Immunol 2021;12:643036. [PMID: 33936061 DOI: 10.3389/fimmu.2021.643036] [Reference Citation Analysis]
8 Barni S, Giovannini M, Liccioli G, Sarti L, Gissi A, Lionetti P, Mori F. Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease. Front Immunol 2021;12:635069. [PMID: 33737936 DOI: 10.3389/fimmu.2021.635069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mitselou A, Grammeniatis V, Varouktsi A, Papadatos SS, Klaroudas A, Katsanos K, Galani V. Immunohistochemical Study of Adhesion Molecules in Irritable Bowel Syndrome: A Comparison to Inflammatory Bowel Diseases. Adv Biomed Res 2021;10:21. [PMID: 34703800 DOI: 10.4103/abr.abr_2_20] [Reference Citation Analysis]